Wei Zhong

Wei Zhong

Company: Wayshine Biopharm

Job title: CEO

Seminars:

Exploring WSD0628: A CNS-Penetrable ATM Inhibitor for Radiosensitization in Recurrent Brain Cancer 2:50 pm

Investigating WSD0628's pharmacokinetic properties to determine its brain penetration efficacy and systemic exposure Evaluating the synergistic effects of WSD0628 combined with radiation therapy in recurrent brain cancer models, focusing on therapeutic outcomes and safety Assessing the impact on survival in preclinical intracranial models, including glioblastoma, DIPG, and brain metastases, to understand potential clinical benefitsRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.